| |
|
|
|
Celldex Therapeutics Inc.  
|
|
0.4721 0.022 (0.05%) |
09-25 16:00 |
|
Open: |
0.45 |
Pre close: |
0.45 |
Target:
|
0.61 
|
|
High: |
0.4888 |
Low: |
0.45 |
Resistance:
|
0.52
0.61
|
|
Volume: |
2,305,264 |
Market Cap: |
77M |
Support:
|
0.45
0.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.44
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.45  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.53 |
Stochastic Oscillator |
%K(14,3):
|
42.75 |
|
MA(250): |
1.71 |
%D(3): |
28.03 |
|
Average Volume(K) |
3-Month: |
143325
|
52-Week |
High:
|
3.26 |
|
10-Days: |
121638 |
Low: |
0.40 |
|
RSI |
RSI(14):
|
57.52 |
Change(%): |
-83.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.610 |
Return on Equity (ttm) |
-90.3 |
Shares Out. (M) |
162.44 |
|
EPS Est. Current Year |
-1.040 |
Return on Assets (ttm) |
-61.9 |
Shares Float (M) |
155.82 |
|
EPS Est. Next Year |
-0.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.280 |
Qtrly Rev. Growth |
-27.8 |
% Held by Institutions |
27.10 |
|
Forward EPS |
-0.818 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3551 |
|
Book Value (p.s.) |
0.540 |
EBITDA (p.s.) |
-0.189 |
P/E |
-0.77 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-89.30 |
P/S |
766879232.00 |
|
Operating Margin |
-679.72 |
Levered Free Cash Flow
(M) |
-55.86 |
P/CF |
-0.86 |
|
|
|
|
|
|
